Tabs/Pages

Pages

Monday, April 2, 2012

PEER evaluation of EEGs??.

I do not know what this PEER is about!!?., but they claim that a EEG evaluation software developed by physicians to address what type of drug treatment regiment can be appropriate for certain mental illness??. I have no idea about what this method or test is about, and I have nothing to say as far as it validity and clinical usefulness, since it is related to neuroscience and monitoring related area, I thought to post it here.

CNS Response Details Response to FDA Feedback on Investigational Device

Company plans to design revised protocol and launch a clinical trial with the Walter Reed National Military Medical Center.
Scottsdale, AZ (PRWEB) March 25, 2012
QualityStocks would like to highlight CNS Response, a publicly traded company providing reference data and analytic tools for clinicians and researchers in psychiatry.
The company offers an online registry, developed by physicians, that enables qualified medical professionals to exchange objective, statistical neurophysiology-based data on individual patient medication response and outcomes.
In the company’s news last week,
CNS Response announced that the U.S. Food and Drug Administration (FDA) has responded to the company’s proposal for a clinical trial of an investigational device, PEER Interactive, designed to help physicians identify the best treatments for certain mental illnesses.
PEER Interactive, a Web service based on a standard electroencephalogram (EEG), records a patient’s brain function much like an electrocardiogram (EKG) does for the heart. The Psychiatric EEG Evaluation Registry (PEER) was developed by physicians as a quality assurance tool to determine which psychiatric medications are effective and which are not.

No comments:

Post a Comment